Description: Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden, and Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. The company was incorporated in 2020 and is based in Lund, Sweden.
Home Page: www.newburypharma.com
Scheeletorget 1
Lund,
223 81
Sweden
Phone:
46 46 12 11 20
Officers
| Name | Title |
|---|---|
| Mr. Karl Alexius Tiger Karlsson | Founder & Executive Chairman |
| Mr. Christoffer Tell | Chief Financial Officer |
| Mr. Fredrik Hellqvist | Vice President of Sales & Marketing |
| Mr. Lars Minor | Chief Executive Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.3103 |
| Price-to-Sales TTM: | 0.2086 |
| IPO Date: | |
| Fiscal Year End: | August |
| Full Time Employees: | 6 |